June 7, 2021
RegMed Investors’ (RMi) pre-open: risk, not too hot but, not to cool to ponder moves
June 4, 2021
RegMed Investors’ (RMi) pre-open: trends and trajectories are just too speculative
June 3, 2021
RegMed Investors’ (RMi) pre-open: the cell and gene therapy sector need to elevate its visibility
June 2, 2021
RegMed Investors’ (RMi) pre-open: trounced or bouncing?
June 1, 2021
RegMed Investors’ (RMi) pre-open: new month
May 28, 2021
RegMed Investors’ (RMi) pre-open: escape, escape
May 27, 2021
RegMed Investors’ (RMi) pre-open: U.S. labor market data expected to hint at the state of the U.S. economy
May 26, 2021
RegMed Investors’ (RMi) pre-open: back in the game, nibbling on some positions
May 25, 2021
RegMed Investors’ (RMi) pre-open: what’s up – market anxiety
May 24, 2021
RegMed Investors’ (RMi) pre-open: heading into the last full trading week of the month
May 21, 2021
RegMed Investors’ (RMi) pre-open: new highs and I say bye cutting some positions
May 20, 2021
RegMed Investors’ (RMi) pre-open: chances of recouping some value
May 19, 2021
RegMed Investors’ (RMi) pre-open: weakness
May 18, 2021
RegMed Investors’ (RMi) pre-open: investor sentiment influence confidence
May 17, 2021
RegMed Investors’ (RMi) pre-open: wham bam, no alakazam
May 14, 2021
RegMed Investors’ (RMi) pre-open: rebound
May 13, 2021
RegMed Investors’ (RMi) pre-open: recovery is creeping higher while many still lose
May 11, 2021
RegMed Investors’ (RMi) pre-open: selling continues, volatility with small volume has been decimating share pricing
May 10, 2021
RegMed Investors’ (RMi) pre-open: is the sector transitory or has a short-lived tenure
May 7, 2021
RegMed Investors’ (RMi) pre-open: a session of share pricing chance
May 6, 2021
RegMed Investors’ (RMi) pre-open: the sell-off battered the sector for the third session this month
May 5, 2021
RegMed Investors’ (RMi) pre-open: slim upside sector pickings
May 4, 2021
RegMed Investors’ (RMi) pre-open: who’s buying and selling our sector
May 3, 2021
RegMed Investors’ (RMi) pre-open: a busy week for earnings
1 hour 41 min ago
RMi pre-open: Cry or
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.